Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan.

Pach A, Tabbusam G, Khan MI, Suhag Z, Hussain I, Hussain E, Mumtaz U, Haq IU, Tahir R, Mirani A, Yousafzai A, Sahastrabuddhe S, Ochiai RL, Soofi S, Clemens JD, Favorov MO, Bhutta ZA.

J Health Commun. 2013;18(3):306-24. doi: 10.1080/10810730.2012.727958. Epub 2013 Jan 18.

PMID:
23330632
2.

Influenza and bacterial pathogen coinfections in the 20th century.

Wang XY, Kilgore PE, Lim KA, Wang SM, Lee J, Deng W, Mo MQ, Nyambat B, Ma JC, Favorov MO, Clemens JD.

Interdiscip Perspect Infect Dis. 2011;2011:146376. doi: 10.1155/2011/146376. Epub 2011 May 11.

3.

Typhoid fever among children, Ghana.

Marks F, Adu-Sarkodie Y, Hünger F, Sarpong N, Ekuban S, Agyekum A, Nkrumah B, Schwarz NG, Favorov MO, Meyer CG, May J.

Emerg Infect Dis. 2010 Nov;16(11):1796-7. doi: 10.3201/eid1611.100388. No abstract available.

4.

The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.

Senouci K, Blau J, Nyambat B, Coumba Faye P, Gautier L, Da Silva A, Favorov MO, Clemens JD, Stoeckel P, Gessner BD.

Vaccine. 2010 Apr 19;28 Suppl 1:A26-30. doi: 10.1016/j.vaccine.2010.02.028.

PMID:
20412992
5.

Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data.

Sharapov MB, Favorov MO, Yashina TL, Brown MS, Onischenko GG, Margolis HS, Chorba TL.

BMC Infect Dis. 2009 Mar 25;9:35. doi: 10.1186/1471-2334-9-35.

6.

[Detection of tuberculosis in the countries of Central Asia by the electronic monitoring system data].

Belilovskiĭ EM, Favorov MO, Aĭtmagambetova I, Ubaĭdullaev AM, Uzakova GT, Iuldashev AA, Ismailov ShSh, Alisherov ASh.

Probl Tuberk Bolezn Legk. 2008;(9):6-13. Russian.

PMID:
19062565
7.

Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.

Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP.

N Engl J Med. 2007 Oct 25;357(17):1685-94. Epub 2007 Oct 18.

8.

Progress toward tuberculosis control and determinants of treatment outcomes--Kazakhstan, 2000-2002.

Bumburidi E, Ajeilat S, Dadu A, Aitmagambetova I, Ershova J, Fagan R, Favorov MO; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2006 Apr 28;55(1):11-5.

PMID:
16645576
9.

Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.

Victor JC, Surdina TY, Suleimenova SZ, Favorov MO, Bell BP, Monto AS.

Am J Epidemiol. 2006 Feb 1;163(3):204-10. Epub 2005 Dec 7.

PMID:
16339053
10.

The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity.

Victor JC, Surdina TY, Suleimeova SZ, Favorov MO, Bell BP, Monto AS.

Epidemiol Infect. 2006 Jun;134(3):492-7. Epub 2005 Sep 30.

11.

[Results of development and introduction of programs for quality control of laboratory diagnostics of infection diseases in Central Asia].

Kalashnikova TV, Musabaev EI, Usmanov RK, Kovtunenko NG, Suleĭmenova SZh, Drobeniuk Zh, Ongarbaev AB, Kuchuk TE, Mustafaeva EM, Avazova DE, Dzhumagulova A, Bobkova MR, Favorov MO.

Klin Lab Diagn. 2005 May;(5):47-51. Russian. No abstract available.

PMID:
15986801
12.

[The results of training laboratory experts from Central Asia in ensuring the quality control in the HIV diagnostics].

Kalashnikova TV, Bobkova MR, Kovtunenko NG, Musabaeva EI, Ongarbaev AB, Favorov MO.

Klin Lab Diagn. 2005 Feb;(2):47-51. Russian. No abstract available.

PMID:
15804101
13.

Complete sequence of a Kyrgyzstan swine hepatitis E virus (HEV) isolated from a piglet thought to be experimentally infected with human HEV.

Lu L, Drobeniuc J, Kobylnikov N, Usmanov RK, Robertson BH, Favorov MO, Margolis HS.

J Med Virol. 2004 Dec;74(4):556-62.

PMID:
15484284
14.

[Detection of antibodies to HIV virus in saliva by express-tests in Uzbekistan].

Ongarbaev AB, Avazova DE, Mustafaeva EM, Drobeniuk Zh, Al'betkova AA, Musabaev EI, Kalashnikova TV, Favorov MO.

Klin Lab Diagn. 2004 Aug;(8):40-2. Russian.

PMID:
15461002
15.

[Subtypes of HBsAg of the hepatitis B virus in Western Siberia].

Netesova IG, Swenson PD, Kalashnikova TV, Netesov SV, Favorov MO.

Vopr Virusol. 2004 Jan-Feb;49(1):17-20. Russian.

PMID:
15017847
16.

[An educational module for organization of a system for controlling quality of laboratory diagnosis of infections for the Central Asia regions].

Kalashnikova TV, Musabaev EI, Usmanov RK, Kuchuk TE, Ongarbaev AB, Mustafaeva EM, Suleĭmenova SZh, Dzhumagulova A, Favorov MO.

Klin Lab Diagn. 2002 Aug;(8):50-3. Russian. No abstract available.

PMID:
12362645
17.

[The quality of laboratory diagnosis of viral hepatitis and analysis of factors affecting the reliability of results].

Dzhumagulova AB, Kalashnikova TV, Drobeniuk Zh, Usmanov RK, Dzhumagulova SK, Kuchuk TE, Sharapov MB, Perdi M, Favorov MO.

Klin Lab Diagn. 2001 Dec;(12):41-4. Russian. No abstract available.

PMID:
11840831
18.

Hepatitis E virus antibody prevalence among persons who work with swine.

Drobeniuc J, Favorov MO, Shapiro CN, Bell BP, Mast EE, Dadu A, Culver D, Iarovoi P, Robertson BH, Margolis HS.

J Infect Dis. 2001 Dec 15;184(12):1594-7. Epub 2001 Dec 3.

PMID:
11740735
19.

Hepatitis E virus infection in chimpanzees: a retrospective analysis.

McCaustland KA, Krawczynski K, Ebert JW, Balayan MS, Andjaparidze AG, Spelbring JE, Cook EH, Humphrey C, Yarbough PO, Favorov MO, Carson D, Bradley DW, Robertson BH.

Arch Virol. 2000;145(9):1909-18.

PMID:
11043950
20.

[Morbidity and mortality in acute viral hepatitides in a hyperendemic region. The role of viral hepatitis E].

Sharapov MB, Favorov MO, Iashina TL, Onishchenko GG, Asadov DA, Chorba TL.

Zh Mikrobiol Epidemiol Immunobiol. 2000 May-Jun;(3):35-9. Russian.

PMID:
10925871
21.

Prevalence of antibody to hepatitis E virus among rodents in the United States.

Favorov MO, Kosoy MY, Tsarev SA, Childs JE, Margolis HS.

J Infect Dis. 2000 Feb;181(2):449-55.

PMID:
10669325
22.

Universal immunization: the diphtheria control strategy of choice in the Republic of Tajikistan, 1993-1997.

Usmanov I, Favorov MO, Chorba TL.

J Infect Dis. 2000 Feb;181 Suppl 1:S86-93.

PMID:
10657197
23.

Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California.

Mast EE, Kuramoto IK, Favorov MO, Schoening VR, Burkholder BT, Shapiro CN, Holland PV.

J Infect Dis. 1997 Jul;176(1):34-40.

PMID:
9207347
24.

Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection.

Yashina TL, Favorov MO, Khudyakov YE, Fields HA, Znoiko OO, Shkurko TV, Bonafonte T, Sevall JS, Agopian MS, Peter JB.

J Infect Dis. 1997 Jun;175(6):1302-7.

PMID:
9180167
25.

Serological survey of markers of infection with viral hepatitis among the Yukpa Amerindians from western Venezuela.

Blitz-Dorfman L, Monsalve F, Atencio R, Porto L, Monzon M, Favorov MO, Fields HA, Pujol FH, Echevarría JM.

Ann Trop Med Parasitol. 1996 Dec;90(6):655-7. No abstract available.

PMID:
9039280
26.

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.

Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN, Khudyakova NS, Jue DL, Onischenko GG, Margolis HS, Fields HA.

J Med Virol. 1996 Sep;50(1):50-8.

PMID:
8890041
27.

[Hepatitis E].

Favorov MO, Iashina TIa, Gol'dberg EZ, Onishchenko GG.

Zh Mikrobiol Epidemiol Immunobiol. 1996 Jul-Aug;(4):90-5. Review. Russian. No abstract available.

PMID:
9027186
28.

Populations with high prevalence of antibody against hepatitis E virus in Israel.

Karetnyi YV, Favorov MO, Khudyakova NS, Bar-Shani S, Dagan R, Fields HA, Mendelson E.

Clin Diagn Virol. 1996 Jun;6(1):73-6. No abstract available.

PMID:
15566892
29.

Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experience.

Fields HA, Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BF, Lambert SB, Jue DL.

Clin Diagn Virol. 1996 May;5(2-3):167-79.

PMID:
15566875
30.

[Prevalence of hepatitis E virus antibodies in pregnant women in the Paris region: serological considerations].

Pillot J, Favorov MO, Grangeot-Keros L, Lazizi Y, Frydman R.

Presse Med. 1995 Sep 23;24(27):1271. French. No abstract available.

PMID:
7501614
31.

Hepatitis E virus infection in hemophiliacs.

Barzilai A, Schulman S, Karetnyi YV, Favorov MO, Levin E, Mendelson E, Weiss P, Fields HA, Varon D, Martinowitz U.

J Med Virol. 1995 Jun;46(2):153-6.

PMID:
7636504
32.

Serological evidence for hepatitis E virus infection in Israel.

Karetnyi YV, Favorov MO, Khudyakova NS, Weiss P, Bar-Shani S, Handsher R, Aboudy Y, Varsano N, Schwartz E, Levin E, et al.

J Med Virol. 1995 Mar;45(3):316-20.

PMID:
7775954
33.

[Synthesis and antigenic activity of peptides from the ORF3 protein sequence of hepatitis E virus].

Semiletov IuA, Dement'evaEV, Iashina TL, Favorov MO, Shibnev VA.

Bioorg Khim. 1995 Feb;21(2):156-7. Russian.

PMID:
7748209
34.

Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India.

Arankalle VA, Jha J, Favorov MO, Chaudhari A, Fields HA, Banerjee K.

J Viral Hepat. 1995;2(4):189-93.

PMID:
7489346
35.

Hepatitis E seroprevalence in selected individuals in South Africa.

Grabow WO, Favorov MO, Khudyakova NS, Taylor MB, Fields HA.

J Med Virol. 1994 Dec;44(4):384-8.

PMID:
7897368
36.

Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.

Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BP, Padhye N, Lambert SB, Jue DL, Fields HA.

J Virol. 1994 Nov;68(11):7067-74.

37.

Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela.

Pujol FH, Favorov MO, Marcano T, Esté JA, Magris M, Liprandi F, Khudyakov YE, Khudyakova NS, Fields HA.

J Med Virol. 1994 Mar;42(3):234-6.

PMID:
8006635
38.

Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides.

Favorov MO, Khudyakov YE, Fields HA, Khudyakova NS, Padhye N, Alter MJ, Mast E, Polish L, Yashina TL, Yarasheva DM, et al.

J Virol Methods. 1994 Feb;46(2):237-50.

PMID:
8188817
39.

Immunodominant antigenic regions in a structural protein of the hepatitis E virus.

Khudyakov YuE, Favorov MO, Jue DL, Hine TK, Fields HA.

Virology. 1994 Jan;198(1):390-3.

PMID:
8259678
40.

Viral hepatitis serological markers among pregnant women in Caracas, Venezuela: implication for perinatal transmission of hepatitis B and C.

Pujol FH, Rodríguez I, Martínez N, Borberg C, Favorov MO, Fields HA, Liprandi F.

G E N. 1994 Jan-Mar;48(1):25-8.

PMID:
7926616
41.

Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV.

Arankalle VA, Favorov MO, Chadha MS, Phule DM, Banerjee K.

Acta Virol. 1993 Dec;37(6):515-8.

PMID:
8010189
42.

[The spread of hepatitis C markers among the population of regions of Russia and Central Asia].

Iashina TL, Favorov MO, Shakhgil'dian IV, Iarasheva DM, Nazarova OI, Derevianko EN, Ommadova MI, Onishchenko GG, Watanabe Y, Nishioka K, et al.

Zh Mikrobiol Epidemiol Immunobiol. 1993 Sep-Oct;(5):46-9. Russian.

PMID:
8067143
43.

[A comparative study of the diagnostic value of peptides, corresponding to various genomic sequences of the hepatitis delta virus].

Semiletov IuA, Kruglov IV, Karpova VA, Iashina TL, Favorov MO.

Mol Gen Mikrobiol Virusol. 1993 Jul-Aug;(4):34-7. Russian.

PMID:
8371725
44.

Synthetic gene for the hepatitis C virus nucleocapsid protein.

Khudyakov YE, Fields HA, Favorov MO, Khudyakova NS, Bonafonte MT, Holloway B.

Nucleic Acids Res. 1993 Jun 11;21(11):2747-54.

45.

Aetiology of acute sporadic non-A, non-B viral hepatitis in India.

Arankalle VA, Chobe LP, Jha J, Chadha MS, Banerjee K, Favorov MO, Kalinina T, Fields H.

J Med Virol. 1993 Jun;40(2):121-5.

PMID:
8360633
46.

[The incidence of detecting hepatitis C viral antibodies in different age groups of the population in northeastern Ukraine].

Tretskaia TA, Shakhgil'dian IV, Iashina TL, Kravchenko VK, Liubchak VA, Mikhno LA, Grechishkin VS, D'iachenko AI, Favorov MO.

Vopr Virusol. 1993 May-Jun;38(3):137-8. Russian.

PMID:
8073754
47.

Epitope mapping in proteins of hepatitis E virus.

Khudyakov YE, Khudyakova NS, Fields HA, Jue D, Starling C, Favorov MO, Krawczynski K, Polish L, Mast E, Margolis H.

Virology. 1993 May;194(1):89-96.

PMID:
7683162
48.
49.

[The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity].

Iashina TL, Favorov MO, Shakhgil'dian IV, Firsova SN, Eraliev AE, Zhukova LD, Reznichenko RG.

Vopr Virusol. 1992 Jul-Aug;37(4):194-6. Russian.

PMID:
1471341
50.

Serologic identification of hepatitis E virus infections in epidemic and endemic settings.

Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, Yarasheva DM, Bradley DW, Margolis HS.

J Med Virol. 1992 Apr;36(4):246-50.

PMID:
1578218

Supplemental Content

Loading ...
Support Center